Kaynaklar

KAYNAKLAR

1. Newall C, et al. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press; 1996: 166.
2. Kreysel HW, et al. A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by Venostatin. Vasa 12: 377–382, 1983.
3. Bougelet C. Effect of aescine on hypoxia induced neutrophil adherence to umbilical vein endothelium. Eur J Pharmacol 345(1): 89–95, 1998.
4. Friederich HC, Vogelsberg H, Neiss A. A contribution to the evaluation of vein medications that work internally (translated from German). Z Hautkr 53(11): 369–374, 1978.
5. Neiss A, Bohm C. Proof of the efficacy of horse chestnut seed extract in the treatment of varicose syndrome (translated from German). Munch Med Wschr 118(7): 213–216, 1976.
6. Bisler H, Pfeifer R, Kluken N, et al. Effect of horse chestnut seed extract on transcapillary filtration in chronic venous insufficiency (translated from German). Dtsch Med Wschr 111: 1321–1329, 1986.
7. Lohr E, Garanin G, Jesau P, et al. Anti-edemic therapy in chronic venous insufficiency with tendency to formation of edema (translated from German). Munch Med Wschr 128(34): 579–581, 1986.
8. Rudofsky G, Neiss A, Otto K, et al. Antiedematous effects and clinical effectiveness of horse chestnut seed extract in double blind studies (translated from German). Phlebologie und Proktologie 15: 47–54, 1986.
9. Steiner M, Hillemanns HG. Investigation of the anti-edemic efficacy of Venostatin (translated from German). Munch Med Wschr 551–552, 1986.
10. Neiss A, Bohm C. Proof of the efficacy of horse chestnut seed extract in the treatment of varicose syndrome (translated from German). Munch Med Wschr 118(7): 213–216, 1976.
11. Lohr E, Garanin G, Jesau P, et al. Anti-edemic therapy in chronic venous insufficiency with tendency to formation of edema (translated from German). Munch Med Wschr 128(34): 579–581, 1986.
12. Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347(8997): 292–294, 1996.
13. Chandler RF. Horse chestnut. Can Pharm J 126(6): 297–300, 306, 1993.
14. Diehm C. The role of oedema protective drugs in the treatment of chronic venous insufficiency: a review of evidence based on placebo-controlled clinical trials with regard to efficacy and tolerance. Phlebology 11: 23–29, 1996.
15. Hitzenberger G. The therapeutic effect of horse chestnut seed extract (translated from German). Wien Med Wschr 139(7): 385–389, 1989.
16. Schulz V, et al. Rational phytotherapy. New York: Springer-Verlag; 1998: 131.
17. Grasso A, Corvaglia E. Two cases of suspected toxic tubulonephrosis due to escine. Gazz Med Ital 135: 581–584, 1976.
18. Reynolds JEF, ed. Martindale, The Extra Pharmacopeia. London: The Pharmaceutical Press; 1989: 1539–1540.
19. Rothkopf M, Vogel G, Lang W, et al. Animal experiments on the question of the renal toleration of the horse chestnut saponin aescin. Arzneimittelforschung 27(3): 598–605, 1977.
20. Takegoshi K, Tohyama T, Okuda K, et al. A case of Venoplant-induced hepatic injury. Gastroenterol Jpn 21(1): 62–65, 1986.
21. Brinker F. Herb Contraindications and Drug Interactions, 2nd ed. Oregon: Eclectic Medical Publications; 1998: 84.
22. Schulz V, et al. Rational phytotherapy. New York: Springer-Verlag; 1998: 132.
23.N.Eröztürk, Bir Yudum Sağlık, Anahtar Yayınları, İstanbul 2000
24.Prof.Dr. Turhan Baytop, Türkiyede Bitkilerle Tedavi, İstanbul Üniv. Ecz. Fak.,1984
25.Dr. Adil Asımgil, Şifalı Bitkiler,Timaş,İstanbul, 1999

26 .Chan AO, Wong BC, Lam SK. Gastric cancer: Past, present and future. Can J Gastroenterol 2001;15:469-474
27. Asghar RJ, Parsonnet J. Helicobacter pylori and risk for gastric adenocarcinoma. Semin Gastrointest Dis 2001;12:203-208
28. Wang TL, Koh TJ. Tumors of the stomach. In: Feldman M, Friedman LS, Sleisenger MH (eds). Sleisenger and Fortdran’s Gastrointestinal and liver disease. 7th. Edition, Elsevier Sciense, 2002, pp. 829-848.
29. Huang XE, Tajima K, Hamajima N, et al. Effects of dietary, drinking, and smoking habits on the prognosis of gastric cancer. Nutr Cancer 2000;38:30-36
30. Süha Göksel. Mide kanseri. In: Topuz E, Aykan F, Demir C (ed), Sindirim sistemi kanserleri.. İstanbul, İ.Ü. Onkoloji Enstitüsü Yayınları, 1998, pp.216-229
31. Miki H, Kobayashi S, Harada H, et al. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroentero. l 2001;36:121-124
32. Inoue H. Treatment of esophageal and gastric tumors. Endoscopy 2001;33:119-125
8. Takao M, Fukuda T, Iwanaga S, et al. Gastric cancer: evaluation of triphasic spiral CT and radiologic pathologic correlation. J Comput Assist Tomogr, 1998;22:288-294
33.Akdoğan RA, Arslan M. In:Özden A, Şahin B, Yılmaz U, Soykan İ (Ed). Gastroenteroloji, TGV, 2002, pp.107-112.
34. Nakamura S, Akzawa K, Yao T. Primary gastrik lyphoma. Cancer, 1995;76:1313-24.
.